levodopa has been researched along with Muscle Rigidity in 131 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 43 (32.82) | 18.7374 |
1990's | 30 (22.90) | 18.2507 |
2000's | 31 (23.66) | 29.6817 |
2010's | 25 (19.08) | 24.3611 |
2020's | 2 (1.53) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Cui, C; Cui, G; Xiao, Q; Xu, C; Zhang, W; Zu, J | 1 |
Biacchi, D; Cariddi, LP; Espay, AJ; Franciotta, D; Gastaldi, M; Mauri, M; Sturchio, A; Versino, M | 1 |
Chang, MC; Lee, HD | 1 |
Cho, H; Lee, MJ; Lee, MS; Lee, SH; Lyoo, CH | 1 |
Konishi, O; Manabe, Y; Odawara, T | 1 |
Eriguchi, M; Hara, H; Hattori, N; Iida, K; Ikeda, S; Nagayama, H; Nishioka, K; Osoegawa, M | 1 |
Hamasaki, T; Kuratsu, J; Yamada, K | 1 |
Ahonen, A; Airaksinen, K; Luoma, J; Mäkelä, JP; Nurminen, J; Pekkonen, E; Taulu, S | 1 |
Gu, X; Han, L; Qiu, W; Tan, D; Ye, J; Zhang, H; Zhang, Y | 1 |
Barlow, SM; Chu, SY; Lee, J | 1 |
Akram, H; Angeli, A; Foltynie, T; Hariz, M; Limousin, P; Zacharia, A; Zrinzo, L | 1 |
Pradhan, S; Tandon, R | 1 |
Hattori, N; Ishiguro, Y; Kawajiri, S; Noda, K; Okuma, Y; Tomizawa, Y; Tosaka, Y | 1 |
Chen, H; Guo, Y; Hao, H; Jia, F; Li, L; Wan, S; Zhang, J | 1 |
Bove, F; Espay, AJ; Espay, KJ; Fasano, A; Krikorian, R; Lena, F; Modugno, N; Poon, YY; Ricciardi, L | 1 |
Ahlskog, JE; Bower, J; Hassan, A; Josephs, KA; Klassen, B; Maraganore, D; Matsumoto, J; Owens, E; Savica, R | 1 |
Agid, Y; Bonnet, AM; Cornu, P; Dormont, D; El Otmani, H; Jodoin, N; Navarro, S; Pidoux, B; Welter, ML; Yaici, S | 1 |
Aasly, JO; Beiske, AG; Bekkelund, SI; Dietrichs, E; Larsen, JP; Tysnes, OB; Vilming, ST | 1 |
Arntzen, KA; Bekkelund, SI; Lilleng, H | 1 |
Aziz, T; Brown, P; Brücke, C; Kühn, AA; Kupsch, A; Ray, N; Schneider, GH; Tsui, A | 1 |
Fernandez, HH; Foote, KD; Garvan, CW; Haq, IU; Hass, CJ; Jacobson, CE; Malaty, IA; Mann, JM; Morishita, T; Okun, MS; Rodriguez, RL; Siddiqui, MS | 1 |
Cordo, PJ; Franzén, E; Gurfinkel, VS; Horak, FB; Nutt, JG; Paquette, C | 1 |
Aeby, A; Blau, N; Burlina, A; de Klerk, JB; de Lonlay, P; de Rijk-van Andel, JF; Donati, MA; Geurtz, B; Grattan-Smith, PJ; Haeussler, M; Hoffmann, GF; Jung, H; Kamsteeg, EJ; Kok, F; Leuzzi, V; Megarbane, A; Monaghan, H; Renier, WO; Rondot, P; Ryan, MM; Seeger, J; Smeitink, JA; Steenbergen-Spanjers, GC; van der Knaap, MS; Verbeek, MM; Wassmer, E; Weschke, B; Wevers, RA; Wijburg, FA; Wilcken, B; Willemsen, MA; Zafeiriou, DI | 1 |
Alterman, R; Martin, C; Tagliati, M | 1 |
Ngamreungphong, S; Nugent, K; Singhatiraj, E | 1 |
Brefel-Courbon, C; Calvas, F; Gerdelat-Mas, A; Marchand-Pauvert, V; Mazevet, D; Meunier, S; Ory-Magne, F; Simonetta-Moreau, M; Vidailhet, M | 1 |
Fung, VS; Latt, MD; Lord, SR; Menant, JC; Menz, HB | 1 |
Rabey, JM; Stocchi, F | 1 |
Grice, T; Stagg, P | 1 |
Budrewicz, S; Jaskólska, A; Jaskólski, A; Koszewicz, M; Marusiak, J | 1 |
Brown, P; Kuhn, AA; Little, S; Pogosyan, A | 1 |
Imamura, T; Kashihara, K | 1 |
Bjarnason, I; Charlett, A; Dobbs, RJ; Dobbs, SM; Iguodala, O; Lawson, AJ; Smee, C; Taylor, D; Weller, C | 1 |
Angelini, L; Blau, N; Fernandez Alvarez, E; Garavaglia, B; Invernizzi, F; Nardocci, N; Pannacci, M; Sesta, M; Zorzi, G | 1 |
Bakay, RA; Barnhart, H; Chockkan, V; DeLong, MR; Evatt, M; Freeman, A; Green, J; Haber, M; McDonald, W; Mewes, K; Triche, S; Vitek, JL; Wahlay, N; Zhang, JY | 1 |
Bembi, B; Capus, L; Carrozzi, M; Ciana, G; Gioulis, M; Martini, C; Pittis, MG; Sidransky, E; Zambito Marsala, S; Zorzon, M | 1 |
Shinohara, Y; Takahashi, H | 1 |
Pagni, CA; Zeme, S; Zenga, F | 1 |
Alam, M; Schmidt, WJ | 1 |
Magnani, P; Mailland, E; Ottillinger, B | 1 |
Widnell, K | 1 |
Aasly, JO; Farrer, M; Fernandez-Mata, I; Hulihan, M; Kachergus, J; Toft, M; White, LR | 1 |
Baba, Y; Putzke, JD; Uitti, RJ; Whaley, NR; Wszolek, ZK | 1 |
Bhat, V; Weiner, WJ | 1 |
Apetauerova, D; Corapi, K; Norregaard, T; O'Herron, S; Scollins, L; Tarsy, D | 1 |
Artuch, R; Camino, R; Lao-Villadóniga, JI; López-Laso, E; Mateos, ME; Ochoa, JJ; Ormazabal, A; Pérez-Navero, JL | 1 |
Cordo, PJ; Gurfinkel, VS; Horak, FB; Nutt, J; Wright, WG | 1 |
Liou, HH; Liu, HM; Su, PC; Tseng, HM; Yen, RF | 1 |
Goto, S; Hamasaki, T; Kuratsu, JI; Yamada, K | 1 |
Krishnappa, D | 1 |
Gabreëls, FJ; Jongen, PJ; Renier, WO | 1 |
Selby, G | 1 |
Narabayashi, H | 4 |
Birkmayer, W; Danielczyk, W; Riederer, P | 1 |
Calne, DB; Newman, RP | 1 |
Bassi, S; Frattola, L; Trabucchi, M | 1 |
Braat, EA; Lighart, GJ; Middelkoop, HA; Roos, RA; van der Velde, EA; van Dijk, JG; van Hilten, JJ | 1 |
Caligiuri, MP | 1 |
Arnold, G; Oertel, WH; Schwarz, J; Trenkwalder, C | 1 |
Caligiuri, MP; Peterson, S | 1 |
Kiauta, T; Mesec, A; Sega, S | 1 |
Auff, E; Doppelbauer, A; Fertl, E; Waldhauser, F | 1 |
Chase, TN; Davis, TL; Giuffra, ME; Mouradian, MM; Sethy, VH | 1 |
Albani, C; Buck, A | 1 |
Chollet, F; Marc-Vergnes, JP; Montastruc, JL; Rascol, A; Rascol, OJ; Sabatini, U | 1 |
Hirato, M; Horikoshi, S; Kawashima, Y; Ohye, C; Satake, K; Shibazaki, T | 1 |
Horstink, MW; Jansen, EN; Roos, RA; Wolters, EC | 1 |
Bösch, S; Kreczy-Kleedorfer, B; Künig, G; Neubauer, M; Ransmayr, G; Wagner, M | 1 |
Caraceni, T; Fetoni, V; Geminiani, GC; Genitrini, S; Giovannini, P; Girotti, F; Parati, EA; Soliveri, P; Testa, D | 1 |
Falk, M; Künig, G; Neubauer, M; Ransmayr, G; Wagner, M | 1 |
DeCarvalho, GC; Kestle, JR; Li, CS; Tasker, RR | 1 |
Kolaj, M; Petravic, D; Relja, MA | 1 |
Bowes, SG; Charlett, A; Dobbs, RJ; Dobbs, SM; Hunt, WB; Kirollos, C; Kosik, R; Mozol, K; Nicholson, PW; O'Neill, CJ; Purkiss, AG; Weller, C | 1 |
Bennett, DJ; Jhamandas, JH; Patrick, SK; Prochazka, A; Roberts, T; Sears-Duru, R; Stephens, MJ | 1 |
Bioulac, B; Boraud, T; Gross, C; Guehl, D; Julien, J; Rougier, A | 1 |
de Yébenes, JG; García-Ruiz, PJ; Sánchez-Pernaute, R | 1 |
Bosch, DA; de Bie, RM; Schuurman, PR; Speelman, JD | 1 |
Coper, H; Konieczny, J; Lorenc-Koci, E; Ossowska, K; Schulze, G; Wolfarth, S | 1 |
Blasko, J; Burkhart, WA; Goiney, RC; Grimm, P; Posewitz, A; Shumway-Cook, A; Vermeulen, SS; Young, RF | 1 |
Saiki, H; Takeuchi, J; Yamagami, T | 1 |
Katayama, Y | 1 |
Konieczny, J; Lorenc-Koci, E; Wardas, J | 1 |
Abe, T; Takahashi, S; Tohgi, H; Utsugisawa, K | 1 |
Côte, LJ; Fahn, S; Levy, G; Louis, ED; Marder, K; Mejia, H | 1 |
Hashimoto, T; Hayashi, R; Ikeda, S; Tada, T | 1 |
Ohye, C | 1 |
Fukaya, C; Kasai, M; Katayama, Y; Mizutani, T; Ogawa, K; Oshima, H; Yamamoto, T | 1 |
Kostić, VS; Marinković, J; Przedborski, S; Stefanova, E; Svetel, M | 1 |
Przuntek, H | 1 |
Marsden, CD; Parkes, JD | 1 |
Adamkov, J; Drobný, M; Fundárek, J; Svaleková, A | 1 |
Baldini, A; Ciottoli, GB; Lisciani, R | 1 |
Halbhübner, K; Herken, H; Loos, D | 1 |
Johnels, B; Steg, G; Ungerstedt, U | 1 |
Agnoli, A; Denaro, A; Lelli, A; Ruggieri, S | 1 |
Calne, DB; Kartzinel, R; Shoulson, I | 1 |
Filion, M; Larochelle, L; Péchadre, JC; Poirier, LJ | 1 |
Bathien, N; Rondot, P | 1 |
Hosaka, A; Imai, H; Miyagawa, F; Nomura, Y; Segawa, M | 1 |
Chalmers, RJ; Johnson, RH; McLellan, DL | 1 |
Asselman, P; Bovill, KT; Marsden, CD; Parkes, JD; Phipps, JA; Rose, P; Tarsy, D | 1 |
Calne, DB | 1 |
Dietrichson, P; Holmsen, R; Presthus, J | 1 |
Schmidt, RT; Spehlmann, R; Stahl, SM | 1 |
Barnett, A; Goldstein, JM; Malick, JB | 1 |
Bakhteev, KK; Brin, IL; Naĭdel', AV | 1 |
Nakashima, K; Takahashi, K | 1 |
Caraceni, T | 1 |
Altus, P; Hencey, MA; Weissman, MS | 1 |
Cunningham, MA; Darby, DG; Donnan, GA | 1 |
Klockgether, T; Turski, L | 1 |
Markova, ED | 1 |
Evtushenko, SK; Mogilevskaia, GS; Osadchiĭ, VG; Ostropolets, SS; Prokhorova, LM; Sadekov, IA; Samsonenko, RA; Va'skovskaia, ME | 1 |
Duret, M; Goldman, S; Hildebrand, J; Messina, D | 1 |
Bratton, M; Jost, MG; Lannon, MC; Lockhart-Pretti, P; Thomas, CA | 1 |
De Cuypere, G; Jannes, C; Remouchamps, A; Tack, E | 1 |
Albers, JW; Albin, RL; Ellis, CN; Silverman, AK; Voorhees, JJ | 1 |
Grundmann, M; Schimrigk, K | 1 |
Backlund, EO | 1 |
Klawans, HL | 1 |
Colpaert, FC | 1 |
Schnaberth, G | 1 |
Bergsrud, D; Elton, RL; Racy, A; Teychenne, PF | 1 |
Indo, T; Takahashi, A | 1 |
Jacobs, BL | 1 |
Eisenlohr, JJ; Gehlen, W | 1 |
Klawans, HL; Topel, JL | 1 |
Borromei, A; Manzini, A | 1 |
10 review(s) available for levodopa and Muscle Rigidity
Article | Year |
---|---|
[Motor symptoms in Parkinson disease].
Topics: Age Factors; Antiparkinson Agents; Deep Brain Stimulation; Dopamine Agonists; Dyskinesias; Dystonia; Humans; Levodopa; Muscle Rigidity; Parkinson Disease; Selegiline; Treatment Outcome; Tremor | 2008 |
[Diagnosis and therapy for patients with vascular parkinsonism].
Topics: Akinetic Mutism; Amantadine; Antiparkinson Agents; Cerebral Infarction; Dementia, Vascular; Diagnosis, Differential; Gait Disorders, Neurologic; Humans; Levodopa; Muscle Rigidity; Parkinson Disease, Secondary; Platelet Aggregation Inhibitors; Posture; Secondary Prevention; Tremor | 2003 |
Pathophysiology of motor fluctuations in Parkinson's disease.
Topics: Adaptation, Physiological; Antiparkinson Agents; Basal Ganglia; Corpus Striatum; Cyclic AMP; Dyskinesia, Drug-Induced; Globus Pallidus; Humans; Hypokinesia; Levodopa; Muscle Rigidity; Neural Pathways; Parkinson Disease; Receptors, Neurotransmitter; Thalamus; Tremor | 2005 |
Parkinson's disease. Diagnosis and the initiation of therapy.
Topics: Antioxidants; Diagnosis, Differential; Dopamine Agonists; Humans; Hypokinesia; Indans; Levodopa; Muscle Rigidity; Nerve Degeneration; Neuroprotective Agents; Parkinson Disease; Parkinsonian Disorders; Selegiline; Tremor | 2005 |
[Details and indications of pallidotomy and thalamotomy for Parkinson's disease].
Topics: Dyskinesia, Drug-Induced; Globus Pallidus; Humans; Levodopa; Muscle Rigidity; Parkinson Disease; Stereotaxic Techniques; Thalamus; Tremor | 2000 |
[Deep brain stimulation(DBS) therapy for parkkinson,s disease].
Topics: Clinical Trials as Topic; Dyskinesia, Drug-Induced; Electric Stimulation Therapy; Globus Pallidus; Humans; Levodopa; Muscle Rigidity; Parkinson Disease; Subthalamic Nucleus; Tremor; Ventral Thalamic Nuclei | 2000 |
Use of selective thalamotomy for various kinds of movement disorder, based on basic studies.
Topics: Antiparkinson Agents; Cerebral Hemorrhage; Chorea; Dyskinesia, Drug-Induced; Dyskinesias; Dystonia; Electrodes, Implanted; Electroencephalography; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Movement Disorders; Muscle Rigidity; Paresthesia; Parkinson Disease; Postoperative Complications; Stereotaxic Techniques; Surgery, Computer-Assisted; Thalamic Nuclei; Tomography, X-Ray Computed; Treatment Outcome; Tremor | 2000 |
[Therapy of tparkinson's disease. Clinical and pharmacological viewpoints].
Topics: Adrenergic beta-Antagonists; Amantadine; Bromocriptine; Histamine H1 Antagonists; Humans; Levodopa; Monoamine Oxidase Inhibitors; MSH Release-Inhibiting Hormone; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Posture; Psychoses, Substance-Induced; Tremor | 1979 |
Physiopathology of experimental Parkinsonism in the monkey.
Topics: Animals; Cerebellum; Corpus Striatum; Disease Models, Animal; Dopamine; Haplorhini; Levodopa; Motor Cortex; Movement Disorders; Muscle Rigidity; Neural Pathways; Olivary Nucleus; Parkinson Disease, Secondary; Red Nucleus; Substantia Nigra; Tremor | 1975 |
Drug treatment of spasticity and rigidity.
Topics: Amantadine; Baclofen; Diazepam; Humans; Levodopa; Mephenesin; Muscle Rigidity; Parasympatholytics; Phenols; Phenothiazines; Spasm; Spinal Nerve Roots | 1975 |
22 trial(s) available for levodopa and Muscle Rigidity
Article | Year |
---|---|
Pathological synchronisation in the subthalamic nucleus of patients with Parkinson's disease relates to both bradykinesia and rigidity.
Topics: Adult; Aged; Aged, 80 and over; Deep Brain Stimulation; Electroencephalography; Evoked Potentials; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Spectrum Analysis; Statistics as Topic; Subthalamic Nucleus | 2009 |
Brain penetration effects of microelectrodes and DBS leads in STN or GPi.
Topics: Aged; Antiparkinson Agents; Combined Modality Therapy; Deep Brain Stimulation; Electrodes, Implanted; Female; Follow-Up Studies; Globus Pallidus; Humans; Hypokinesia; Levodopa; Male; Microelectrodes; Middle Aged; Movement; Muscle Rigidity; Neurosurgical Procedures; Parkinson Disease; Subthalamic Nucleus; Treatment Outcome; Tremor | 2009 |
Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Catechols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Dysarthria; Facial Expression; Female; Humans; Hypokinesia; Indans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Motor Activity; Muscle Rigidity; Nitriles; Parkinson Disease; Severity of Illness Index; Tremor | 2011 |
Randomized trial of pallidotomy versus medical therapy for Parkinson's disease.
Topics: Antiparkinson Agents; Atrophy; Brain; Carbidopa; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Combinations; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Globus Pallidus; Humans; Hypokinesia; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Rigidity; Neurosurgical Procedures; Parkinson Disease; Severity of Illness Index; Treatment Outcome; Tremor | 2003 |
Further experience with extradural motor cortex stimulation for treatment of advanced Parkinson's disease. Report of 3 new cases.
Topics: Aged; Deglutition Disorders; Dura Mater; Dyskinesia, Drug-Induced; Electric Stimulation Therapy; Electrodes; Electrodes, Implanted; Female; Gait Disorders, Neurologic; Humans; Levodopa; Magnetic Resonance Imaging; Male; Motor Cortex; Muscle Rigidity; Parkinson Disease; Treatment Outcome; Tremor | 2003 |
Alpha-dihydroergocryptine in the long-term therapy of Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Dihydroergocryptine; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Posture; Psychomotor Performance; Speech Disorders; Tremor | 2004 |
Milacemide therapy for Parkinson's disease.
Topics: Acetamides; Aged; Carbidopa; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Muscle Rigidity; Neurologic Examination; Parkinson Disease; Receptors, N-Methyl-D-Aspartate; Single-Blind Method; Synaptic Transmission | 1993 |
Superior clinical efficacy of Sinement CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open and a double-blind, double-dummy, multicenter treatment evaluation. Dutch Sinement CR Study Group.
Topics: Antiparkinson Agents; Carbidopa; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Humans; Levodopa; Movement Disorders; Muscle Rigidity; Neurologic Examination; Parkinson Disease | 1993 |
Effect of age and disease duration on parkinsonian motor scores under levodopa therapy.
Topics: Adult; Aged; Aging; Antiparkinson Agents; Bromocriptine; Disease Progression; Female; Gait; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Psychomotor Performance; Tremor | 1995 |
Does thalamotomy alter the course of Parkinson's disease?
Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Combined Modality Therapy; Disease Progression; Female; Follow-Up Studies; Functional Laterality; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Thalamus; Treatment Outcome; Tremor | 1996 |
Quantifying rigidity with a new computerized elbow device.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Elbow Joint; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Reproducibility of Results | 1996 |
Objective measurement of activation of rigidity: diagnostic, pathogenetic and therapeutic implications in parkinsonism.
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Female; Hand Strength; Humans; Isometric Contraction; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Physical Exertion; Reproducibility of Results; Sensitivity and Specificity; Torque; Trihexyphenidyl | 1996 |
Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.
Topics: Adult; Aged; Antiparkinson Agents; Electric Stimulation Therapy; Female; Follow-Up Studies; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Severity of Illness Index; Subthalamic Nucleus; Time Factors; Treatment Outcome; Tremor | 2001 |
The effect of stage of Parkinson's disease at the onset of levodopa therapy on development of motor complications.
Topics: Age of Onset; Aged; Antiparkinson Agents; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Movement; Muscle Rigidity; Parkinson Disease; Sex Characteristics; Tremor | 2002 |
Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Tremor | 1976 |
Clinical and pharmacological evaluation of the effects of piribedil in patients with parkinsonism.
Topics: Aged; Antiparkinson Agents; Chorea; Clinical Trials as Topic; Confusion; Dioxoles; Dopamine; Drug Evaluation; Electromyography; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Middle Aged; Motor Skills; Muscle Rigidity; Nausea; Parkinson Disease; Parkinson Disease, Postencephalitic; Piperazines; Pyrimidines; Tremor | 1975 |
Amphetamines in the treatment of Parkinson's disease.
Topics: Aged; Amantadine; Amphetamine; Clinical Trials as Topic; Female; Humans; Isomerism; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Parkinson Disease, Postencephalitic; Posture; Structure-Activity Relationship; Tremor | 1975 |
[Effect of small doses of L-dopa on synergic tonic reaction in patients with childhood cerebral palsy].
Topics: Adolescent; Adult; Cerebral Palsy; Child; Electromyography; Humans; Leg; Levodopa; Movement; Muscle Contraction; Muscle Hypotonia; Muscle Rigidity; Muscles; Neural Conduction; Tibial Nerve | 1992 |
[Clinical results of using Nakom in diseases of the nervous system].
Topics: Adolescent; Adult; Age Factors; Carbidopa; Catecholamines; Cerebral Palsy; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Dystonia Musculorum Deformans; Humans; Levodopa; Muscle Rigidity; Myasthenia Gravis | 1989 |
Effect of L-dopa on dementia-related rigidity.
Topics: Aged; Aged, 80 and over; Dementia; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity | 1989 |
Levodopa and monoamine oxidase inhibitor combination therapy. A controlled clinical trial.
Topics: Aged; Benserazide; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Muscle Rigidity; Parkinson Disease; Parkinson Disease, Secondary; Tremor | 1987 |
[Levodopa as a single treatment of Parkinsonism. Long-term control of 24 cases with discrimination analysis].
Topics: Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Female; Follow-Up Studies; Humans; Levodopa; Male; Methods; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Pyramidal Tracts; Time Factors; Tremor | 1974 |
99 other study(ies) available for levodopa and Muscle Rigidity
Article | Year |
---|---|
Comparative Analysis of Acute Levodopa Challenge Test and the Outcomes of Deep Brain Stimulation in Parkinson's Disease.
Topics: Deep Brain Stimulation; Humans; Hypokinesia; Levodopa; Muscle Rigidity; Parkinson Disease; Subthalamic Nucleus; Treatment Outcome | 2022 |
Levodopa-responsive progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor antibodies.
Topics: Adult; Autoantibodies; Autoimmune Diseases of the Nervous System; Benserazide; Dopamine Agents; Drug Combinations; Encephalomyelitis; Humans; Levodopa; Male; Muscle Rigidity; Myoclonus; Receptors, Glycine | 2021 |
Degeneration of the corticofugal tract from the secondary motor area in a Parkinson's disease patient with limb-kinetic apraxia: A case report.
Topics: Anisotropy; Antiparkinson Agents; Benserazide; Diffusion Tensor Imaging; Drug Combinations; Female; Humans; Levodopa; Middle Aged; Motor Cortex; Muscle Rigidity; Muscular Atrophy, Spinal; Parkinson Disease; Positron-Emission Tomography; Tremor | 2017 |
Impaired finger dexterity and nigrostriatal dopamine loss in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Apraxias; Arm; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Female; Fingers; Functional Laterality; Humans; Hypokinesia; Imaging, Three-Dimensional; Levodopa; Male; Middle Aged; Motor Skills; Muscle Rigidity; Parkinson Disease; Positron-Emission Tomography; Severity of Illness Index; Substantia Nigra | 2018 |
Fact-finding survey on diagnostic procedures and therapeutic interventions for parkinsonism accompanying dementia with Lewy bodies.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Lewy Body Disease; Middle Aged; Muscle Rigidity; Neurologists; Parkinsonian Disorders; Physicians; Postural Balance; Psychiatry; Psychotropic Drugs; Tremor | 2019 |
Parkinsonism Relating to Intoxication with Glyphosate.
Topics: Adult; Glycine; Glyphosate; Herbicides; Humans; Levodopa; Magnetic Resonance Imaging; Male; Muscle Rigidity; Parkinson Disease; Treatment Outcome | 2019 |
Thalamic stimulation alleviates levodopa-resistant rigidity in a patient with non-Parkinson's disease parkinsonian syndrome.
Topics: Aged; Deep Brain Stimulation; Humans; Levodopa; Male; Muscle Rigidity; Parkinsonian Disorders; Thalamus | 2014 |
Cortico-muscular coherence in advanced Parkinson's disease with deep brain stimulation.
Topics: Aged; Cerebral Cortex; Deep Brain Stimulation; Electromyography; Female; Humans; Levodopa; Magnetoencephalography; Male; Middle Aged; Muscle Rigidity; Muscle, Skeletal; Parkinson Disease; Subthalamic Nucleus; Tremor | 2015 |
[Tyrosine hydroxylase deficiency: a case of autosomal recessive dopa-responsive dystonia].
Topics: Brain; Catecholamines; Child, Preschool; DNA; DNA Mutational Analysis; Dopamine Agents; Dystonic Disorders; Homozygote; Humans; Hypokinesia; Levodopa; Male; Muscle Rigidity; Mutation, Missense; Polymerase Chain Reaction; Tyrosine 3-Monooxygenase | 2014 |
Face-referenced measurement of perioral stiffness and speech kinematics in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Biomechanical Phenomena; Case-Control Studies; Electromyography; Face; Facial Muscles; Female; Humans; Labial Frenum; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Regression Analysis; Speech | 2015 |
Varying time-course of effects of high frequency stimulation of sub-regions of the globus pallidus in patients with parkinson's disease.
Topics: Aged; Antiparkinson Agents; Combined Modality Therapy; Deep Brain Stimulation; Dyskinesias; Female; Follow-Up Studies; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Time Factors; Treatment Outcome; Tremor | 2015 |
Progressive supra-nuclear palsy: frequency of cardinal extrapyramidal features at first presentation.
Topics: Accidental Falls; Aged; Antiparkinson Agents; Diagnosis, Differential; Disease Progression; Early Diagnosis; Female; Humans; India; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Posture; Practice Guidelines as Topic; Prevalence; Supranuclear Palsy, Progressive | 2015 |
Delayed chorea after recovery from severe akinetic-rigid parkinsonism caused by extrapontine myelinolysis.
Topics: Carbidopa; Chorea; Disease Progression; Dopamine Agonists; Drug Combinations; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Myelinolysis, Central Pontine; Parkinsonian Disorders | 2015 |
Variable frequency stimulation of subthalamic nucleus for freezing of gait in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Combined Modality Therapy; Deep Brain Stimulation; Dopamine Agonists; Gait Disorders, Neurologic; Humans; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Pramipexole; Subthalamic Nucleus | 2015 |
24-Hour infusion of levodopa/carbidopa intestinal gel for nocturnal akinesia in advanced Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Muscle Rigidity; Outcome Assessment, Health Care; Parkinson Disease; Sleep Wake Disorders | 2016 |
The clinical spectrum and natural history of pure akinesia with gait freezing.
Topics: Aged; Aged, 80 and over; Dopamine Agents; Female; Follow-Up Studies; Freezing Reaction, Cataleptic; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Neuroimaging; Postural Balance; Psychomotor Performance; Retrospective Studies | 2016 |
[Can subthalamic nucleus stimulation reveal parkinsonian rest tremor?].
Topics: Adrenal Rest Tumor; Antiparkinson Agents; Deep Brain Stimulation; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Neurosurgical Procedures; Parkinson Disease; Subthalamic Nucleus; Tremor | 2009 |
[Subacute worsening of rigidity in a patient with Parkinson disease].
Topics: Aged; Antiparkinson Agents; Brain Neoplasms; Disease Progression; Glioblastoma; Humans; Levodopa; Magnetic Resonance Imaging; Male; Muscle Rigidity; Muscle Spasticity; Parkinson Disease | 2008 |
Reduced performance in balance, walking and turning tasks is associated with increased neck tone in Parkinson's disease.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Analysis of Variance; Case-Control Studies; Disability Evaluation; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Neck; Parkinson Disease; Postural Balance; Psychomotor Performance; Severity of Illness Index; Walking | 2009 |
Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis.
Topics: Age of Onset; Amino Acid Metabolism, Inborn Errors; Brain; Brain Diseases; Catecholamines; Child, Preschool; Disease Progression; Dopamine Agents; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Hypokinesia; Infant; Levodopa; Muscle Rigidity; Mutation, Missense; Phenotype; Promoter Regions, Genetic; Severity of Illness Index; Tyrosine 3-Monooxygenase | 2010 |
Lack of motor symptoms progression in Parkinson's disease patients with long-term bilateral subthalamic deep brain stimulation.
Topics: Aged; Deep Brain Stimulation; Disease Progression; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Retrospective Studies; Subthalamic Nucleus; Treatment Outcome; Tremor | 2010 |
Acute dopamine depletion syndrome.
Topics: Aged; Alzheimer Disease; Confusion; Creatine Kinase; Dopamine; Dopamine Agents; Female; Fever; Humans; Hypothyroidism; Levodopa; Muscle Rigidity; Parkinson Disease | 2010 |
Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's disease.
Topics: Adult; Aged; Analysis of Variance; Antiparkinson Agents; Deep Brain Stimulation; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Reflex | 2011 |
Postural sway approaches center of mass stability limits in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Neurologic Examination; Parkinson Disease; Postural Balance; Posture; Reproducibility of Results; Sensation Disorders; Statistics as Topic | 2011 |
Nasogastric medication for perioperative Parkinson's rigidity during anaesthesia emergence.
Topics: Amantadine; Anesthesia; Anesthesia Recovery Period; Anesthesia, General; Antiparkinson Agents; Carbidopa; Drug Combinations; Fracture Fixation, Internal; Fractures, Bone; Humans; Humerus; Intraoperative Awareness; Intubation, Gastrointestinal; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Perioperative Care | 2011 |
Myometry revealed medication-induced decrease in resting skeletal muscle stiffness in Parkinson's disease patients.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Body Mass Index; Electromyography; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Muscle Contraction; Muscle Rigidity; Muscle, Skeletal; Parkinson Disease; Piribedil; Stress, Mechanical | 2012 |
β band stability over time correlates with Parkinsonian rigidity and bradykinesia.
Topics: Aged; Basal Ganglia; Beta Rhythm; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Time Factors | 2012 |
Frequency and clinical correlates of retrocollis in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Levodopa; Male; Muscle Rigidity; Neck; Neuropsychological Tests; Parkinson Disease; Posture; Torticollis | 2013 |
Antimicrobial surveillance in idiopathic parkinsonism: indication-specific improvement in hypokinesia following Helicobacter pylori eradication and non-specific effect of antimicrobials for other indications in worsening rigidity.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiparkinson Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hypokinesia; Intestine, Small; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinsonian Disorders; Treatment Outcome | 2013 |
Neonatal dopa-responsive extrapyramidal syndrome in twins with recessive GTPCH deficiency.
Topics: Adolescent; Antiparkinson Agents; Basal Ganglia Diseases; Carbidopa; Dopamine Agents; Dystonia; Female; Follow-Up Studies; Genes, Recessive; GTP Cyclohydrolase; Homozygote; Humans; Infant, Newborn; Infant, Newborn, Diseases; Levodopa; Metabolism, Inborn Errors; Muscle Rigidity; Mutation; Reflex, Abnormal; Remission Induction; Treatment Outcome; Tremor | 2003 |
Gaucher's disease with Parkinson's disease: clinical and pathological aspects.
Topics: Adult; Age of Onset; Aged; Anemia; Antiparkinson Agents; Disease Progression; DNA Mutational Analysis; Drug Resistance; Female; Gaucher Disease; Glucosylceramidase; Hepatomegaly; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Recombinant Proteins; Siblings; Splenomegaly; Thrombocytopenia; Tremor | 2003 |
L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats.
Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Benserazide; Corpus Striatum; Dopamine; Drug Synergism; Electron Transport Complex I; Levodopa; Male; Motor Activity; Motor Skills; Muscle Rigidity; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Rotenone; Substantia Nigra; Uncoupling Agents | 2004 |
Clinical features of LRRK2-associated Parkinson's disease in central Norway.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Antiparkinson Agents; Female; Heterozygote; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Levodopa; Male; Middle Aged; Muscle Rigidity; Mutation; Norway; Parkinson Disease; Pedigree; Protein Serine-Threonine Kinases; Tremor | 2005 |
Gender and the Parkinson's disease phenotype.
Topics: Activities of Daily Living; Age of Onset; Analysis of Variance; Antiparkinson Agents; Chi-Square Distribution; Cohort Studies; Databases, Factual; Depression; Female; Functional Laterality; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Phenotype; Retrospective Studies; Sex Factors; Time Factors; Tremor | 2005 |
Progression of Parkinson's disease following thalamic deep brain stimulation for tremor.
Topics: Aged; Deep Brain Stimulation; Disease Progression; Follow-Up Studies; Gait; Humans; Hypokinesia; Levodopa; Middle Aged; Motor Skills; Muscle Rigidity; Parkinson Disease; Severity of Illness Index; Thalamus; Tremor; Verbal Behavior | 2005 |
Dopa-responsive infantile hypokinetic rigid syndrome due to dominant guanosine triphosphate cyclohydrolase 1 deficiency.
Topics: Antiparkinson Agents; Family Health; Female; GTP Cyclohydrolase; Humans; Hypokinesia; Infant; Levodopa; Male; Muscle Rigidity; Retrospective Studies | 2007 |
Axial hypertonicity in Parkinson's disease: direct measurements of trunk and hip torque.
Topics: Abdomen; Acceleration; Aged; Antiparkinson Agents; Female; Hip; Humans; Levodopa; Male; Middle Aged; Muscle Hypertonia; Muscle Rigidity; Parkinson Disease; Posture; Rotation; Severity of Illness Index; Thorax; Torque | 2007 |
Bilateral subthalamotomy for advanced Parkinson disease.
Topics: Aged; Catheter Ablation; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Functional Laterality; Humans; Hypokinesia; Levodopa; Male; Microelectrodes; Middle Aged; Muscle Rigidity; Neural Pathways; Parkinson Disease; Radiosurgery; Subthalamic Nucleus; Time; Treatment Outcome; Tremor | 2007 |
Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Deep Brain Stimulation; Dyskinesias; Electrodes, Implanted; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Posture; Psychoses, Substance-Induced; Retrospective Studies; Subthalamic Nucleus; Tremor | 2008 |
Juvenile variant of Huntington's chorea. An expression of disturbed neurotransmission.
Topics: Adult; Female; Humans; Huntington Disease; Levodopa; Male; Muscle Rigidity; Synaptic Transmission | 1984 |
Seven cases of Huntington's disease in childhood and levodopa induced improvement in the hypokinetic--rigid form.
Topics: Adolescent; Child; Child, Preschool; Female; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Infant; Levodopa; Male; Muscle Rigidity | 1980 |
The natural history of Parkinson's disease.
Topics: Activities of Daily Living; Dementia; Dysarthria; Gait; Humans; Levodopa; Movement Disorders; Muscle Rigidity; Parkinson Disease; Thalamus; Time Factors; Tremor | 1984 |
Pharmacological basis of akinesia in Parkinson's disease.
Topics: Brain; Dopamine; Humans; Levodopa; Movement Disorders; Muscle Rigidity; Norepinephrine; Parkinson Disease; Receptors, Dopamine; Tremor | 1983 |
Symptoms and side effects in the course of Parkinson's disease.
Topics: Autonomic Nervous System Diseases; Dementia; Diagnosis, Differential; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Movement Disorders; Muscle Rigidity; Parkinson Disease; Psychoses, Substance-Induced; Receptors, Dopamine | 1983 |
Diagnosis and management of Parkinson's disease.
Topics: Bromocriptine; Diagnosis, Differential; Humans; Levodopa; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Tremor | 1984 |
Clinical analysis of akinesia.
Topics: Dopamine; Humans; Levodopa; Motor Skills; Movement Disorders; Muscle Rigidity; Parkinson Disease; Thalamus | 1980 |
Effect of naloxone on the "on-off' syndrome in patients receiving long-term levodopa therapy.
Topics: Aged; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Naloxone; Parkinson Disease; Receptors, Dopamine | 1982 |
Hypokinesia in Parkinson's disease: influence of age, disease severity, and disease duration.
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Circadian Rhythm; Drug Therapy, Combination; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Motor Activity; Muscle Rigidity; Neurologic Examination; Parkinson Disease | 1995 |
Portable device for quantifying parkinsonian wrist rigidity.
Topics: Adult; Aged; Antiparkinson Agents; Antipsychotic Agents; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Muscle Tonus; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Psychotic Disorders; Risk Factors; Transducers | 1994 |
Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug-induced psychosis.
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Dibenzothiepins; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Muscle Rigidity; Neurologic Examination; Parkinson Disease; Psychoses, Substance-Induced; Tremor | 1994 |
A quantitative study of levodopa-induced dyskinesia in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Basal Ganglia; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Tremor | 1993 |
The influence of the type, duration, severity and levodopa treatment of Parkinson's disease on cardiovascular autonomic responses.
Topics: Adult; Aged; Cardiovascular System; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Severity of Illness Index; Tremor | 1993 |
Circadian secretion pattern of melatonin in de novo parkinsonian patients: evidence for phase-shifting properties of l-dopa.
Topics: Aged; Circadian Rhythm; Female; Humans; Levodopa; Male; Melatonin; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Radioimmunoassay; Tremor | 1993 |
Early detection of L-dopa response in parkinsonian patients with a standardized tracking test.
Topics: Adult; Basal Ganglia; Benserazide; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Movement Disorders; Muscle Rigidity; Neurologic Examination; Orientation; Parkinson Disease; Psychomotor Performance; Signal Processing, Computer-Assisted; Tremor | 1993 |
Impaired activity of the supplementary motor area in akinetic patients with Parkinson's disease. Improvement by the dopamine agonist apomorphine.
Topics: Aged; Apomorphine; Brain; Dopamine; Female; Humans; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Motor Activity; Motor Cortex; Movement Disorders; Muscle Rigidity; Neurologic Examination; Parkinson Disease; Regional Blood Flow; Somatosensory Cortex; Tomography, Emission-Computed, Single-Photon | 1993 |
Different cerebral metabolism between parkinsonian rigidity and hyperkinesia (DID, chorea, dystonia). A PET study.
Topics: Basal Ganglia; Blood Glucose; Brain Mapping; Cerebral Cortex; Chorea; Dominance, Cerebral; Dystonia; Energy Metabolism; Humans; Hyperkinesis; Levodopa; Muscle Rigidity; Neural Pathways; Oxygen Consumption; Parkinson Disease; Thalamic Nuclei; Tomography, Emission-Computed | 1993 |
Is the decreasing responsiveness of axial motor symptoms to L-dopa in elderly parkinsonian patients related to age-associated nonparkinsonian pathologies?
Topics: Age Factors; Aged; Brain; Dementia; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Motor Activity; Motor Skills; Movement Disorders; Muscle Rigidity; Neurologic Examination; Parkinson Disease | 1993 |
Response to L-DOPA in multiple system atrophy.
Topics: Adult; Aged; Carbidopa; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Movement; Movement Disorders; Muscle Rigidity; Olivopontocerebellar Atrophies; Parkinson Disease; Tremor | 1993 |
Measurement of rigidity in Parkinson's disease.
Topics: Antiparkinson Agents; Humans; Levodopa; Muscle Rigidity; Neurologic Examination; Parkinson Disease; Reproducibility of Results; Transducers | 1997 |
High-frequency stimulation of the globus pallidus internalis in Parkinson's disease: a study of seven cases.
Topics: Adult; Disease Progression; Dyskinesia, Drug-Induced; Electric Stimulation Therapy; Electrodes, Implanted; Follow-Up Studies; Gait; Globus Pallidus; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Speech Disorders; Stereotaxic Techniques; Thalamic Nuclei; Treatment Outcome; Tremor | 1997 |
[A comparative study of the effect of bromocriptine and pergolide on Parkinson disease].
Topics: Aged; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Pergolide; Retrospective Studies; Tremor | 1997 |
Bilateral posteroventral pallidotomy in advanced Parkinson's disease in three patients.
Topics: Activities of Daily Living; Age of Onset; Antiparkinson Agents; Drug Resistance; Dyskinesia, Drug-Induced; Dystonia; Female; Follow-Up Studies; Globus Pallidus; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Pilot Projects; Prospective Studies; Severity of Illness Index; Treatment Outcome | 1997 |
Muscle rigidity induced by fluphenazine in rats is antagonized by L-DOPA, an antiparkinsonian drug.
Topics: Animals; Antiparkinson Agents; Antipsychotic Agents; Dopamine Antagonists; Female; Fluphenazine; Levodopa; Muscle Rigidity; Rats; Rats, Wistar | 1998 |
Gamma knife radiosurgery as a lesioning technique in movement disorder surgery.
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Dopamine Agents; Dyskinesia, Drug-Induced; Electroencephalography; Female; Follow-Up Studies; Gait; Globus Pallidus; Hemianopsia; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Motor Skills; Movement Disorders; Muscle Rigidity; Neuropsychological Tests; Parkinson Disease; Radiosurgery; Radiotherapy Dosage; Safety; Single-Blind Method; Thalamus; Tremor | 1998 |
Pallidotomy revisited. Analysis of posteroventral pallidotomy.
Topics: Aged; Dyskinesia, Drug-Induced; Globus Pallidus; Humans; Levodopa; MMPI; Movement Disorders; Muscle Rigidity; Parkinson Disease; Postoperative Period; Stereotaxic Techniques; Thalamic Nuclei; Thalamus; Treatment Outcome; Tremor | 1997 |
SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Ankle Joint; Dopamine Agents; Dopamine Antagonists; Drug Combinations; Electromyography; Haloperidol; Levodopa; Male; Muscle Contraction; Muscle Rigidity; Muscle, Skeletal; Neostriatum; Neuroprotective Agents; Parkinsonian Disorders; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, Purinergic P1; Reserpine; Triazoles | 2001 |
Symptomatic characteristics of parkinsonism and the width of substantia nigra pars compacta on MRI according to ischemic changes in the putamen and cerebral white matter: implications for the diagnosis of vascular parkinsonism.
Topics: Aged; Antiparkinson Agents; Brain Infarction; Brain Ischemia; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Motor Activity; Muscle Rigidity; Parkinson Disease; Parkinson Disease, Secondary; Putamen; Substantia Nigra | 2001 |
Clinical correlates of action tremor in Parkinson disease.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Antiparkinson Agents; Arm; Female; Humans; Hypokinesia; Levodopa; Male; Mental Status Schedule; Middle Aged; Motor Activity; Movement; Muscle Rigidity; Parkinson Disease; Physical Examination; Posture; Rest; Tremor; Video Recording | 2001 |
Relation between changes in long-latency stretch reflexes and muscle stiffness in Parkinson's disease--comparison before and after unilateral pallidotomy.
Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Dementia; Electromyography; Female; Functional Laterality; Globus Pallidus; Hand; Humans; Levodopa; Male; Middle Aged; Motor Neurons; Muscle Rigidity; Muscle, Skeletal; Parkinson Disease; Reaction Time; Reflex, Stretch; Wrist Joint | 2001 |
"On-off" effects in patients with Parkinson's disease on chronic levodopa therapy.
Topics: Dose-Response Relationship, Drug; Half-Life; Levodopa; Long-Term Care; Movement Disorders; Muscle Rigidity; Parkinson Disease; Time Factors | 1976 |
[Therapy of rigidity and hypokinesis in old age using Sinemet].
Topics: Aged; Carbidopa; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Movement Disorders; Muscle Rigidity; Parkinson Disease, Postencephalitic; Trihexyphenidyl | 1979 |
Behavioral study on the interactions between trazodone and L-dopa.
Topics: Animals; Behavior, Animal; Drug Interactions; Female; Haloperidol; Imipramine; Levodopa; Male; Mice; Muscle Rigidity; Piperazines; Time Factors; Trazodone | 1979 |
Lisuride, a potent drug in the treatment of muscular rigisity in rats.
Topics: Animals; Antiparkinson Agents; Disease Models, Animal; Ergolines; Levodopa; Male; Muscle Rigidity; Rats; Urea | 1977 |
A method for mechanographical recording of muscle tone in the rat: the effect of some antiparkinsonian drugs on rigidity induced by reserpine.
Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Carbidopa; Drug Evaluation, Preclinical; Haloperidol; Levodopa; Male; Muscle Rigidity; Muscle Tonus; Myography; Rats; Reserpine | 1978 |
Parkinson's disease improvement after the addition of levodopa-carbidopa to anticholinergic treatment. An open controlled study.
Topics: Administration, Oral; Adult; Aged; Carbidopa; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease, Secondary; Tremor; Trihexyphenidyl | 1978 |
Reciprocal continuous inhibition in rigidity of Parkinsonism.
Topics: Adult; Aged; H-Reflex; Humans; Levodopa; Middle Aged; Muscle Rigidity; Muscles; Neural Inhibition; Parkinson Disease; Peroneal Nerve; Procaine | 1977 |
Hereditary progressive dystonia with marked diurnal fluctuation.
Topics: Adolescent; Adult; Child; Circadian Rhythm; Dystonia Musculorum Deformans; Electroencephalography; Female; Humans; Levodopa; Middle Aged; Muscle Contraction; Muscle Rigidity; Muscles; Neural Conduction; Pedigree; Posture; Reflex, Monosynaptic; Sleep; Tremor | 1976 |
Treatment of parkinsonism with l-dopa and a decarboxylase inhibitor. An electrophysiological and clinical study.
Topics: Aged; Carboxy-Lyases; Drug Combinations; Drug Evaluation; Electrophysiology; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Muscle Tonus; Parkinson Disease; Tremor | 1975 |
A pharmacologic study of the stiff-man syndrome. Correlation of clinical symptoms with urinary 3-methoxy-4-hydroxy-phenyl glycol excretion.
Topics: Diazepam; Glycine; Glycols; Homovanillic Acid; Humans; Levodopa; Male; Metanephrine; Methoxyhydroxyphenylglycol; Middle Aged; Muscle Rigidity; Normetanephrine; Physostigmine; Spasm; Syndrome; Vanilmandelic Acid | 1975 |
The evaluation of anti-parkinson drugs on reserpine-induced rigidity in rats.
Topics: Amantadine; Animals; Antiparkinson Agents; Apomorphine; Benztropine; Carbidopa; Hindlimb; Levodopa; Male; Methamphetamine; Muscle Rigidity; Rats; Reserpine; Scopolamine; Time Factors; Trihexyphenidyl | 1975 |
Exteroceptive suppression of the masseter and temporalis muscles and parkinsonian rigidity.
Topics: Adult; Aged; Amantadine; Basal Ganglia; Bromocriptine; Electric Stimulation; Electromyography; Female; Humans; Levodopa; Male; Masseter Muscle; Middle Aged; Muscle Rigidity; Muscle Spindles; Parkinson Disease; Temporal Muscle; Trigeminal Nerve; Trihexyphenidyl | 1991 |
The diagnosis of multiple system atrophy.
Topics: Atrophy; Autonomic Nervous System Diseases; Cerebellar Diseases; Diagnosis, Differential; Humans; Levodopa; Muscle Rigidity | 1991 |
A 73-year-old woman with confusion, rigidity, and fever.
Topics: Aged; Carbidopa; Confusion; Drug Therapy, Combination; Female; Fever; Humans; Levodopa; Muscle Rigidity; Neuroleptic Malignant Syndrome; Parkinson Disease | 1991 |
Controlled-release delivery of L-dopa associated with nonfatal hyperthermia, rigidity, and autonomic dysfunction.
Topics: Adult; Autonomic Nervous System Diseases; Benserazide; Delayed-Action Preparations; Drug Combinations; Fever; Humans; Levodopa; Male; Muscle Rigidity; Parkinson Disease | 1991 |
NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats.
Topics: Animals; Dizocilpine Maleate; Drug Synergism; Electromyography; Levodopa; Male; Methyltyrosines; Motor Activity; Muscle Rigidity; N-Methylaspartate; Parkinson Disease; Piperazines; Rats; Rats, Inbred Strains; Reserpine | 1990 |
[Characteristics of the clinical course, pathogenesis and treatment of torsion dystonia in childhood].
Topics: Adolescent; Child; Dystonia Musculorum Deformans; Genes, Dominant; Genes, Recessive; Humans; Levodopa; Muscle Rigidity; Polymorphism, Genetic | 1989 |
Comprehensive care of the patient with Parkinson's disease.
Topics: Aged; Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Patient Care Planning; Patient Care Team; Tremor | 1986 |
Levodopa addiction. A case study.
Topics: Adult; Dermatitis, Seborrheic; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Muscle Rigidity; Paranoid Disorders; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Risk Factors; Substance Withdrawal Syndrome; Substance-Related Disorders | 1988 |
A new syndrome of axial muscle rigidity associated with etretinate therapy.
Topics: Adult; Antiparkinson Agents; Back; Carbidopa; Drug Combinations; Etretinate; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Neck Muscles; Psoriasis; Syndrome | 1988 |
Transplantation to the brain--a new therapeutic principle or useless venture?
Topics: Adrenal Medulla; Animals; Brain; Forecasting; Humans; Levodopa; Muscle Rigidity; Neurosurgery; Parkinson Disease; Stereotaxic Techniques; Tomography, X-Ray Computed | 1987 |
Individual manifestations of Parkinson's disease after ten or more years of levodopa.
Topics: Gait; Handwriting; Humans; Levodopa; Middle Aged; Muscle Rigidity; Parkinson Disease; Posture; Prognosis; Speech; Time Factors; Tremor | 1986 |
Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat.
Topics: Animals; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Female; Haloperidol; Levodopa; Monoamine Oxidase Inhibitors; Movement Disorders; Muscle Rigidity; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Reserpine; Swimming; Sympatholytics; Time Factors; Tremor | 1987 |
["Parkinson plus." Multisystem involvement in Parkinson disease].
Topics: Brain Ischemia; Dopamine; Humans; Levodopa; Muscle Rigidity; Neurocognitive Disorders; Parkinson Disease | 1986 |
Bromocriptine: long-term low-dose therapy in Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Movement; Muscle Rigidity; Parkinson Disease; Tremor | 1986 |
An analysis of long-term L-dopa therapy in 122 cases of Parkinson's disease over 14 years--when should L-dopa therapy be initiated?
Topics: Adult; Aged; Female; Gait; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Prognosis; Receptors, Dopamine; Time Factors; Tremor | 1986 |
Evidence for the functional interaction of two central neurotransmitters.
Topics: Anilides; Animals; Behavior, Animal; Cinnamates; Dopamine; Dopamine Antagonists; Drug Interactions; Fenclonine; Levodopa; Male; Methyltyrosines; Methysergide; Muscle Rigidity; Neurotransmitter Agents; Pargyline; Pimozide; Rats; Serotonin; Serotonin Antagonists; Sulfides; Synaptic Transmission; Tremor; Tryptophan | 1974 |
[Long-term study on the anti-rigidity effect of L-dopa and a decarboxylase inhibitor (ro 8-0576) (author's transl)].
Topics: Aged; Antiparkinson Agents; Carboxy-Lyases; Drug Synergism; Female; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Muscle Rigidity; Myography; Parkinson Disease | 1974 |
Possible role of cerebellar circuits in parkinsonian symptoms.
Topics: Aged; Animals; Cats; Cerebellar Diseases; Cerebellum; Female; Haplorhini; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Neural Pathways; Parkinson Disease; Thalamic Nuclei; Tremor | 1974 |
Parkinsonism as a falling sickness.
Topics: Age Factors; Aged; Amantadine; Female; Gait; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Neurologic Examination; Parasympatholytics; Parkinson Disease; Posture; Reflex; Remission, Spontaneous; Tremor | 1974 |